---
pmid: '30344101'
title: 'Unproven Stem Cell Therapies in India: Regulatory Challenges and Proposed
  Paths Forward.'
authors:
- Tiwari SS
- Desai PN
journal: Cell Stem Cell
year: '2018'
full_text_available: false
doi: 10.1016/j.stem.2018.10.007
---

# Unproven Stem Cell Therapies in India: Regulatory Challenges and Proposed Paths Forward.
**Authors:** Tiwari SS, Desai PN
**Journal:** Cell Stem Cell (2018)
**DOI:** [10.1016/j.stem.2018.10.007](https://doi.org/10.1016/j.stem.2018.10.007)

## Abstract

1. Cell Stem Cell. 2018 Nov 1;23(5):649-652. doi: 10.1016/j.stem.2018.10.007.
Epub  2018 Oct 18.

Unproven Stem Cell Therapies in India: Regulatory Challenges and Proposed Paths 
Forward.

Tiwari SS(1), Desai PN(2).

Author information:
(1)Canadian Institute for Genomics and Society, Suite 333, 637 Lake Shore 
Boulevard West, Toronto, ON M5V 3J6, Canada. Electronic address: 
shashank17t@gmail.com.
(2)Retired Professor, Centre for Studies in Science Policy, Jawaharlal Nehru 
University, New Delhi-110067, India.

Hundreds of clinics in India offer unproven stem cell therapies despite having 
remarkably stringent guidelines and regulations for fraudulent advertisements 
and clinical practice. We discuss the challenges with current regulations, how a 
recently proposed amendment may further legitimize unproven stem cell therapies, 
and discuss paths forward in a global context.

Copyright Â© 2018 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.stem.2018.10.007
PMID: 30344101 [Indexed for MEDLINE]
